Physician profile
Mary E Nagle
NPI 1518253848
$4,001.42
in general payments reported to CMS, 2019-2025
42 companies · $1,085 in 2025
The $1,085 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $954 · 2020: $191 · 2021: $102 · 2022: $349 · 2023: $637 · 2024: $683 · 2025: $1,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,404.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $555.58 | 2019-2025 | |
| Glaxosmithkline, LLC. | $382.93 | 2022-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Novo Nordisk INC | $377.17 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $358.17 | 2019-2025 | Farxiga, Airsupra |
| Amgen INC. | $333.44 | 2019-2025 | Evenity, Repatha, Otezla |
| Abbvie INC. | $227.87 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.35 | 2019-2024 | Jardiance, Synjardy |
| Lilly USA, LLC | $170.65 | 2019-2025 | Jardiance, Emgality, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $142.08 | 2022-2023 | |
| Exact Sciences Corporation | $135.44 | 2023-2025 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $110.66 | 2024 | Voquezna |
| Kite Pharma, INC. | $104.49 | 2025 | Yescarta |
| Teva Pharmaceuticals USA, INC. | $104.01 | 2019-2025 | Ajovy, Austedo Xr |
| Dexcom, INC. | $78.43 | 2023-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $67.88 | 2019-2023 | Xifaxan |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Nagle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.